Home › Funds › GUGGENHEIM CAPITAL LLC › VRTX

GUGGENHEIM CAPITAL LLC position in VRTX

VERTEX PHARMACEUTICALS INC · Health Care

GUGGENHEIM CAPITAL LLC reported holding 115,233 shares of VRTX (VERTEX PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$57.2M, representing 0.37% of its reported portfolio and ranking #44 among its reported holdings. GUGGENHEIM CAPITAL LLC has disclosed VRTX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)115.23K sh
Reported value held$57.24M
Portfolio Weight0.37%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How GUGGENHEIM CAPITAL LLC's VRTX position evolved

GUGGENHEIM CAPITAL LLC first disclosed a stake in VRTX in Q3 2023 at 161,878 shares (US$56.3M). The position peaked in Q2 2024 at 159,687 shares, worth US$74.8M. Across 12 filings, GUGGENHEIM CAPITAL LLC increased the stake 3 time(s), trimmed it 8 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 115,233 shares valued at US$57.2M — an increase of 14,847 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 161.88K $56.29M New
Q4 2023 171.66K $69.85M Add
Q1 2024 165.70K $69.26M Reduce
Q2 2024 159.69K $74.85M Reduce
Q3 2024 139.29K $64.78M Reduce
Q4 2024 135.69K $54.64M Reduce
Q1 2025 102.00K $49.45M Reduce
Q2 2025 101.22K $45.06M Reduce
Q3 2025 103.12K $40.39M Add
Q4 2025 101.04K $45.81M Reduce
Q1 2026 100.39K $44.83M Reduce
Q2 2026 115.23K $57.24M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VRTX and 13F data

VRTX (VERTEX PHARMACEUTICALS INC) is a Health Care company. 33 other funds we track also report a position in VRTX — the largest reported positions include Capital World Investors (US$12.97B), Capital World Investors (US$12.97B), Capital Research Global Investors (US$9.68B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VRTX

All VRTX fund holders →

FAQ

How long has GUGGENHEIM CAPITAL LLC held VRTX?

GUGGENHEIM CAPITAL LLC has disclosed VRTX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is GUGGENHEIM CAPITAL LLC's current position in VRTX?

As of Q2 2026, GUGGENHEIM CAPITAL LLC holds 115.23K shares of VRTX (VERTEX PHARMACEUTICALS INC), valued at $57.24M, representing 0.37% of its reported portfolio and ranking #44.

Has GUGGENHEIM CAPITAL LLC been buying or selling VRTX?

In the latest 13F filing (Q2 2026), GUGGENHEIM CAPITAL LLC increased its position in VRTX. The position peaked in Q2 2024 at 159.69K shares.

Which other funds hold VRTX?

Other major institutional holders of VRTX include Capital World Investors, Capital World Investors, Capital Research Global Investors, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.